Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Apotheek Breugelhof from Tienen, company number BE0885934355, closed financial year 2025 with a result of € -16,247 after tax. For that financial year Apotheek Breugelhof recorded a gross margin of € 230,121 and equity of € 116,275. Compared with financial year 2024, the result moved from € -4,204 to € -16,247. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 116,275
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -16,247
▼ 286 % more loss than in 2024
Profit after tax over the fiscal year.
€ 85,830
▼ 46% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 66,275.
People and assets in 2025
2.4
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 144,238
▲ 22% vs 2024
€ 60,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 1.1 million
▲ 8% vs 2024
€ 117,943 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 86,710
▼ 39% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,744
▼ 17% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 118,798 | € 133,405 | € 190,822 | € 230,121 | ▲ 21% |
| Profit after taxes | € -108,973 | € -103,355 | € -4,204 | € -16,247 | ▼ € 12,043 |
| Equity | € 240,082 | € 136,727 | € 132,522 | € 116,275 | ▼ 12% |
| Total debts | € 1,326,072 | € 1,222,363 | € 1,215,888 | € 1,232,033 | ▲ 1% |
| Cash | € 343,379 | € 152,727 | € 158,465 | € 85,830 | ▼ 46% |
| Land & buildings | € 718,343 | € 702,964 | € 687,585 | € 679,122 | ▼ 1% |
| Retained profit | € 190,082 | € 86,727 | € 82,522 | € 66,275 | ▼ 20% |
| Bank debt | € 1,145,840 | € 1,064,282 | € 997,337 | € 1,080,740 | ▲ 8% |
| Balance sheet total | € 1,566,154 | € 1,359,090 | € 1,348,410 | € 1,348,308 | |
| Employees (FTE) | 2 | 1.8 | 1.7 | 2.4 | ▲ 0.7 |
Key figures of Apotheek Breugelhof, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Breugelhof?
What happened at Apotheek Breugelhof in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 16,247. Source: NBB ↗
- Pille en Kamille BV became a director. NBB
- ROEL FIEY MANAGEMENT BV became a director. NBB
- New establishment in Tienen. KBO
- Start of the company according to the CBE. KBO
In short
From € 108,973 loss in 2022 to € 16,247 loss in 2025.
On average € 95,900 of value added per employee in 2025.
A new publication or filing at Apotheek Breugelhof? We notify you, reason included.
Follow Apotheek BreugelhofDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Apotheek Breugelhof are Pille en Kamille BV and ROEL FIEY MANAGEMENT BV. The shares are held by Pille en Kamille and ROEL FIEY MANAGEMENT.
Directors
According to the 2025 annual accounts
Director · represented by Sabine Vanelderen
since 2022
Director · represented by Roel Fiey
Also active at: Apotheek DE ZWAANTJES, FARMACIE AN-JOLIE, Pharmacie Flawinne, PHARMACIE NAIM, PHARMACIE DU PERRON, FARMACIE AN -JOLIE, PHARMACIE D'HELECINE, FARMACIE HENRI +3 more
since 2022
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kabbeekvest-Breughelhof 1
3300 Tienen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0885.934.355
- VAT number
- BE 0885.934.355
- Registered office
- Kabbeekvest-Breughelhof 1, 3300 Tienen
- Names & denominations
- Apotheek Breugelhof
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2006
- Peppol
- Active · Active since 31 Mar 2026
- Contact
- apotheekbreugelhof.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Vervaardiging van geneesmiddelen
Vervaardiging van andere organische chemische basisproducten
Vervaardiging van overige organische chemische basisproducten